News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
The symposium at BIOHK2024 is starting out strong with welcoming remarks by AFCR CEO, Sujuan Ba
Photo taken from AFCR/X
Sep 12, 2024, 09:18

The symposium at BIOHK2024 is starting out strong with welcoming remarks by AFCR CEO, Sujuan Ba

Asian Fund for Cancer Research (AFCR) shared on X

“The symposium at BIOHK2024 is starting out strong with welcoming remarks by our CEO, Dr. Sujuan Ba, and board member, Dr. Michael Yang. Immediately following the welcome remarks came Dr. Kucherlapati to discuss precision medicine in drug development.”

BIOHK2024

Source: AFCR/X

More posts featuring CityU-AFCR Symposium on oncodaily.com

AFCR BIOHK2024 cancer CityU-AFCR Symposium Michael Yang OncoDaily Oncology Raju Kucherlapati Sujuan Ba
Special Coverage
Blog
Feb 21, 2025, 09:18
Belén Garijo: A very important evolution of Merck Group's Executive Board
Blog
Feb 21, 2025, 09:07
Karen Knudsen: Integrating technology into clinical practice
Blog
Feb 21, 2025, 09:00
ICCD 2025 Event Highlights: Speakers’ Quote Series - SIOP Europe
Blog
Feb 21, 2025, 08:48
Emily Drake: Delivery of palliative and end-of-life care for AYAs living with cancer
Blog
Feb 21, 2025, 08:19
Chibuike Okafor: How Amgen Defeated the ‘Undruggable’ KRAS
Insight
Feb 21, 2025, 06:20
Gustavo Viani: New Evidence on Elective CTV in Early Anal Cancer
Blog
Feb 21, 2025, 06:10
Afreen Shariff: Start-ups are about persistence, grit and being comfortable with being uncomfortable
Radiotherapy
Feb 21, 2025, 04:51
Radiotherapy For Breast Cancer: Types, Success Rate, Side Effects And More
Library
Feb 20, 2025, 16:36
New Paper Alert: Systemic management of advanced HCC: an increasingly complex game
Blog
Feb 20, 2025, 14:43
MD Anderson Cancer Center and Texas Children's Hospital announced a collaboration dedicated solely to pediatric cancer care
Blog
Feb 20, 2025, 11:21
Thor Halfdanarson: Should Liver resection in patients with high-grade neuroendocrine neoplasms be considered?
Blog
Feb 20, 2025, 11:19
Jill Feldman: My Guiding Compass in Advocacy